Wegovy® (semaglutide injection) Receives Conditional Marketing Authorization from Health Canada as the First and Only Treatment for Adults with Non-Cirrhotic MASH…

Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with ...
Fierce Pharma

Novo’s oral semaglutide edges out CagriSema, Lilly’s orforglipron as PCPs’ most-anticipated obesity med

The survey showed that while most of the doctors didn’t have top-of-mind awareness of oral semaglutide’s upcoming FDA ...
Le Lézard

PureHealth Research Launches Natural Vein Health Supplements for Youthful-Looking Legs

PureHealth Research today announced the launch of its new line of vein health supplements, offering a natural approach to supporting healthy circulation and promoting the appearance of ...
Le Lézard

Aviceda Therapeutics Announces Phase 2b SIGLEC Results for AVD-104 in Geographic Atrophy

Aviceda Therapeutics ("the Company" or "Aviceda"), a clinical-stage biotechnology company developing innovative therapies for retinal diseases, today announced topline results from its SIGLEC Phase 2b ...
Labiotech.eu

Keep an eye on these 15 biotech companies in 2026

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...